Atea Pharmaceuticals AVIR Earnings Call Transcripts

NASDAQ AVIR
$4.22 +0.02 (+0.48%)
At close: Nov 11, 2026 · 4:00 PM EST
10 earnings calls on file for Atea Pharmaceuticals, from Q4 2020 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Atea Pharmaceuticals Q3 2026 Earnings Call

Nov 9, 2026 4,796 words · 21 min read
  • Jean-Pierre SommadossiChief Executive Officer and Founder
  • Maria Arantxa HorgaChief Medical Officer
  • Janet J. HammondChief Development Officer
  • John F. VavrickaChief Commercial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Atea Pharmaceuticals Earnings Call Transcripts

Calls10
LatestNov 9, 2026
SinceQ4 2020

Fiscal 2026

Fiscal 2025

Fiscal 2022

Fiscal 2021

Fiscal 2020

All 10 Atea Pharmaceuticals transcripts Register to get access to Atea Pharmaceuticals’s earnings call transcripts.